Phillips AN - Search Results

1

Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression.

Smith CJ, Phillips AN, Dauer B, Johnson MA, Lampe FC, Youle MS, Tyrer M, Staszewski S. Smith CJ, et al. Among authors: phillips an. HIV Med. 2009 Jan;10(1):19-27. doi: 10.1111/j.1468-1293.2008.00650.x. Epub 2008 Nov 10. HIV Med. 2009. PMID: 19018880 Free article.

2

Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages.

Janossy G, Borthwick N, Lomnitzer R, Medina E, Squire SB, Phillips AN, Lipman M, Johnson MA, Lee C, Bofill M. Janossy G, et al. Among authors: phillips an. AIDS. 1993 May;7(5):613-24. doi: 10.1097/00002030-199305000-00002. AIDS. 1993. PMID: 8318170

3

Unrecognised HIV infection among gynaecology patients.

Olaitan A, Madge S, McCarthy KH, Phillips AN, Johnson MA. Olaitan A, et al. Among authors: phillips an. Br J Obstet Gynaecol. 1996 May;103(5):470-3. doi: 10.1111/j.1471-0528.1996.tb09776.x. Br J Obstet Gynaecol. 1996. PMID: 8624323 No abstract available.

4

Will we ever know when to treat HIV infection?

Phillips AN, Smith GD, Johnson MA. Phillips AN, et al. BMJ. 1996 Sep 7;313(7057):608-10. doi: 10.1136/bmj.313.7057.608. BMJ. 1996. PMID: 8806255 Free PMC article. Review.

5

Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.

Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, Janossy G. Bofill M, et al. Among authors: phillips an. AIDS. 1996 Jul;10(8):827-34. doi: 10.1097/00002030-199607000-00005. AIDS. 1996. PMID: 8828739

6

HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.

Phillips AN, Eron JJ, Bartlett JA, Rubin M, Johnson J, Price S, Self P, Hill AM. Phillips AN, et al. AIDS. 1996 Jul;10(8):859-65. doi: 10.1097/00002030-199607000-00009. AIDS. 1996. PMID: 8828743 Clinical Trial.

7

Factors affecting survival in patients with the acquired immunodeficiency syndrome.

Mocroft A, Johnson MA, Phillips AN. Mocroft A, et al. Among authors: phillips an. AIDS. 1996 Sep;10(10):1057-65. AIDS. 1996. PMID: 8874621

8

Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.

Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Mocroft A, et al. Among authors: phillips an. AIDS. 1996 Sep;10(10):1101-5. AIDS. 1996. PMID: 8874626 Clinical Trial.

9

Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.

Phillips AN, Eron J, Bartlett J, Kuritzkes DR, Johnson VA, Gilbert C, Johnson J, Keller A, Hill AM. Phillips AN, et al. AIDS. 1997 Feb;11(2):169-75. doi: 10.1097/00002030-199702000-00006. AIDS. 1997. PMID: 9030363

10

Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.

Mocroft A, Youle M, Morcinek J, Sabin CA, Gazzard B, Johnson MA, Phillips AN. Mocroft A, et al. Among authors: phillips an. BMJ. 1997 Feb 8;314(7078):409-13. doi: 10.1136/bmj.314.7078.409. BMJ. 1997. PMID: 9040386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters